Published Date: 02 Mar 2023
New research suggests that cidofovir may be a helpful option for tender joints or joints.
Read Full NewsBreast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality. Precisely predicting whether ...
The periodization of exercise training could give people undergoing cancer treatment and those in recovery a tailored pathway to support strength and resilience during the challenging journey of cancer care and rehabilitation.
A new clinical trial led by University of Alberta researchers is exploring whether heavy strength training is a safe and beneficial way to help combat the long-term physical challenges faced by head and neck cancer survivors.
1.
Novel radiotracer identifies biomarker for triple-negative breast cancer
2.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
3.
EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.
4.
Ineffective medication can remove the "worst fear" of schizophrenia.
5.
Cancer mortality continuing to decline, says report
1.
The Millionaire's Battle: Does Mark Cuban Have Cancer?
2.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
3.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
4.
Intravenous Calcium for Reducing Blood Loss During Cesarean Delivery: A Review of Current Evidence
5.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation